Glucagon-like peptide-1 receptor agonists have been shown to decrease complication rates in spine patients, and for ACDF patients they may provide some benefit after surgery, according to a study in ...
Leading spine societies have issued a powerful new consensus statement urging insurers to reimburse for interbody devices in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results